Logo Light ModeLogo Dark Mode
Why Subscribe?About UsAccreditationLearning Hub CentralLive EventsBlog

Learning Hub Central

Loading…

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure

Learning Hub Central

Filter by title, faculty, or specialty to find the course you're looking for.

SpecialtyBreast(251 courses)
All specialties

Breast

251 courses

2026 MaTOS Breast | Faculty PDF Access

2026 MaTOS Breast | Faculty PDF Access

0.00 Credits
31 Chapters
Breast
$100,000.00
2026 Winter Cancer Symposium | Optimal Therapy for Metastatic Triple Negative Breast Cancer

2026 Winter Cancer Symposium | Optimal Therapy for Metastatic Triple Negative Breast Cancer

0.00 Credits
1 Chapter
Breast
Free
2026 Winter Cancer Symposium | New therapies for Metastatic Hormone Receptor Positive Breast Cancer: Sequencing SERDs, CDKi, PI3Ki and ADCs

2026 Winter Cancer Symposium | New therapies for Metastatic Hormone Receptor Positive Breast Cancer: Sequencing SERDs, CDKi, PI3Ki and ADCs

0.00 Credits
1 Chapter
Breast
Free
2026 Winter Cancer Symposium | HER2 Positive Breast Cancer: Individualizing Treatment to Biology and Response

2026 Winter Cancer Symposium | HER2 Positive Breast Cancer: Individualizing Treatment to Biology and Response

0.00 Credits
1 Chapter
Breast
Free
2026 Winter Cancer Symposium | Early-stage Hormone Receptor Positive Breast Cancer: Targeting Therapy to Risk Balanced with Toxicity

2026 Winter Cancer Symposium | Early-stage Hormone Receptor Positive Breast Cancer: Targeting Therapy to Risk Balanced with Toxicity

0.00 Credits
1 Chapter
Breast
Free
2026 MCM | Triple Negative Breast Cancer: Immunotherapy and Novel Therapies

2026 MCM | Triple Negative Breast Cancer: Immunotherapy and Novel Therapies

0.00 Credits
1 Chapter
Breast
Free
2026 MCM | Applying New Endocrine and Targeted Agents to the Treatment of Hormone Receptor Positive, HER2 Negative Breast Cancer

2026 MCM | Applying New Endocrine and Targeted Agents to the Treatment of Hormone Receptor Positive, HER2 Negative Breast Cancer

0.00 Credits
1 Chapter
Breast
Free
2026 MCM | New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer

2026 MCM | New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer

0.00 Credits
1 Chapter
Breast
Free
2026 MCM | Antibody Drug Conjugates for Breast Cancer

2026 MCM | Antibody Drug Conjugates for Breast Cancer

0.00 Credits
1 Chapter
Breast
Free
2026 Updates in Cancer Therapies | New Therapies for Metastatic Hormone Receptor Positive Breast  Cancer: Sequencing SERDs, CDKi, PI3Ki and ADCs

2026 Updates in Cancer Therapies | New Therapies for Metastatic Hormone Receptor Positive Breast Cancer: Sequencing SERDs, CDKi, PI3Ki and ADCs

0.00 Credits
1 Chapter
Breast
Free
2026 Updates in Cancer Therapies | Optimal Therapy for Early-Stage Triple Negative Breast Cancer

2026 Updates in Cancer Therapies | Optimal Therapy for Early-Stage Triple Negative Breast Cancer

0.00 Credits
1 Chapter
Breast
Free
2026 Updates in Cancer Therapies | HER2 Positive Breast Cancer: Individualizing Treatment to Biology and Response

2026 Updates in Cancer Therapies | HER2 Positive Breast Cancer: Individualizing Treatment to Biology and Response

0.00 Credits
1 Chapter
Breast
Free
2026 Updates in Cancer Therapies | Early-stage Hormone Receptor Positive Breast Cancer: Targeting Therapy to Risk Balanced with Toxicity

2026 Updates in Cancer Therapies | Early-stage Hormone Receptor Positive Breast Cancer: Targeting Therapy to Risk Balanced with Toxicity

0.00 Credits
1 Chapter
Breast
Free
2025 MLS Seattle | Triple Negative Breast Cancer Updates

2025 MLS Seattle | Triple Negative Breast Cancer Updates

0.00 Credits
1 Chapter
Breast
Free
2025 MLS Seattle | HER2-Positive Breast Cancer Updates

2025 MLS Seattle | HER2-Positive Breast Cancer Updates

0.00 Credits
1 Chapter
Breast
Free
2025 Breast Cancer Symposium | Updates in Antibody Drug Conjugates

2025 Breast Cancer Symposium | Updates in Antibody Drug Conjugates

0.00 Credits
1 Chapter
Breast
Free
2025 Breast Cancer Symposium | Radiation Oncology - De-escalation and When Not to De-escalate

2025 Breast Cancer Symposium | Radiation Oncology - De-escalation and When Not to De-escalate

0.00 Credits
1 Chapter
Breast
Free
2025 Breast Cancer Symposium | Don’t Discount the Patient

2025 Breast Cancer Symposium | Don’t Discount the Patient

0.00 Credits
1 Chapter
Breast
Free
2025 Breast Cancer Symposium | EQUITY EQUITY EQUITY

2025 Breast Cancer Symposium | EQUITY EQUITY EQUITY

0.00 Credits
1 Chapter
Breast
Free
2025 Breast Cancer Symposium | HER2neu Positive - Updates in Early and Advanced Disease

2025 Breast Cancer Symposium | HER2neu Positive - Updates in Early and Advanced Disease

0.00 Credits
1 Chapter
Breast
Free
2025 Breast Cancer Symposium | HRT and the Breast Cancer Patient

2025 Breast Cancer Symposium | HRT and the Breast Cancer Patient

0.00 Credits
1 Chapter
Breast
Free
2025 Breast Cancer Symposium | Sexual Health

2025 Breast Cancer Symposium | Sexual Health

0.00 Credits
1 Chapter
Breast
Free
2025 Breast Cancer Symposium | HR Positive - Updates in Early and Advanced Breast Cancer

2025 Breast Cancer Symposium | HR Positive - Updates in Early and Advanced Breast Cancer

0.00 Credits
1 Chapter
Breast
Free
2025 Breast Cancer Symposium | Genetics - Deleterious Gene Mutations and their Application to Screening and Treatment

2025 Breast Cancer Symposium | Genetics - Deleterious Gene Mutations and their Application to Screening and Treatment

0.00 Credits
1 Chapter
Breast
Free
2025 Breast Cancer Symposium | Breast Diagnostics - Updates in Imaging

2025 Breast Cancer Symposium | Breast Diagnostics - Updates in Imaging

0.00 Credits
1 Chapter
Breast
Free
Showing 25 of 251 courses

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure